201 related articles for article (PubMed ID: 15640688)
1. Leukocyte adhesion deficiency III: a group of integrin activation defects in hematopoietic lineage cells.
Etzioni A; Alon R
Curr Opin Allergy Clin Immunol; 2004 Dec; 4(6):485-90. PubMed ID: 15640688
[TBL] [Abstract][Full Text] [Related]
2. Defects in the leukocyte adhesion cascade.
Etzioni A
Clin Rev Allergy Immunol; 2010 Feb; 38(1):54-60. PubMed ID: 19437145
[TBL] [Abstract][Full Text] [Related]
3. LAD-III, a leukocyte adhesion deficiency syndrome associated with defective Rap1 activation and impaired stabilization of integrin bonds.
Kinashi T; Aker M; Sokolovsky-Eisenberg M; Grabovsky V; Tanaka C; Shamri R; Feigelson S; Etzioni A; Alon R
Blood; 2004 Feb; 103(3):1033-6. PubMed ID: 14551137
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adhesion deficiencies: molecular basis, clinical findings, and therapeutic options.
Etzioni A
Adv Exp Med Biol; 2007; 601():51-60. PubMed ID: 17712991
[TBL] [Abstract][Full Text] [Related]
5. A novel genetic leukocyte adhesion deficiency in subsecond triggering of integrin avidity by endothelial chemokines results in impaired leukocyte arrest on vascular endothelium under shear flow.
Alon R; Aker M; Feigelson S; Sokolovsky-Eisenberg M; Staunton DE; Cinamon G; Grabovsky V; Shamri R; Etzioni A
Blood; 2003 Jun; 101(11):4437-45. PubMed ID: 12595312
[TBL] [Abstract][Full Text] [Related]
6. Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3.
Jurk K; Schulz AS; Kehrel BE; Räpple D; Schulze H; Möbest D; Friedrich WW; Omran H; Deak E; Henschler R; Scheele JS; Zieger B
Thromb Haemost; 2010 May; 103(5):1053-64. PubMed ID: 20216991
[TBL] [Abstract][Full Text] [Related]
7. Immunopathologies linked to integrin signalling.
Wang H; Lim D; Rudd CE
Semin Immunopathol; 2010 Jun; 32(2):173-82. PubMed ID: 20217414
[TBL] [Abstract][Full Text] [Related]
8. A novel syndrome of variant leukocyte adhesion deficiency involving defects in adhesion mediated by beta1 and beta2 integrins.
Harris ES; Shigeoka AO; Li W; Adams RH; Prescott SM; McIntyre TM; Zimmerman GA; Lorant DE
Blood; 2001 Feb; 97(3):767-76. PubMed ID: 11157496
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands.
Bunting M; Harris ES; McIntyre TM; Prescott SM; Zimmerman GA
Curr Opin Hematol; 2002 Jan; 9(1):30-5. PubMed ID: 11753075
[TBL] [Abstract][Full Text] [Related]
10. A novel leukocyte adhesion deficiency III variant: kindlin-3 deficiency results in integrin- and nonintegrin-related defects in different steps of leukocyte adhesion.
Robert P; Canault M; Farnarier C; Nurden A; Grosdidier C; Barlogis V; Bongrand P; Pierres A; Chambost H; Alessi MC
J Immunol; 2011 May; 186(9):5273-83. PubMed ID: 21441448
[TBL] [Abstract][Full Text] [Related]
11. LAD-III, a novel group of leukocyte integrin activation deficiencies.
Alon R; Etzioni A
Trends Immunol; 2003 Oct; 24(10):561-6. PubMed ID: 14552841
[TBL] [Abstract][Full Text] [Related]
12. Leukocyte adhesion deficiency-I variant syndrome (LAD-Iv, LAD-III): molecular characterization of the defect in an index family.
Harris ES; Smith TL; Springett GM; Weyrich AS; Zimmerman GA
Am J Hematol; 2012 Mar; 87(3):311-3. PubMed ID: 22139635
[TBL] [Abstract][Full Text] [Related]
13. Mice lacking the signaling molecule CalDAG-GEFI represent a model for leukocyte adhesion deficiency type III.
Bergmeier W; Goerge T; Wang HW; Crittenden JR; Baldwin AC; Cifuni SM; Housman DE; Graybiel AM; Wagner DD
J Clin Invest; 2007 Jun; 117(6):1699-707. PubMed ID: 17492052
[TBL] [Abstract][Full Text] [Related]
14. Novel aspects of Kindlin-3 function in humans based on a new case of leukocyte adhesion deficiency III.
Meller J; Malinin NL; Panigrahi S; Kerr BA; Patil A; Ma Y; Venkateswaran L; Rogozin IB; Mohandas N; Ehlayel MS; Podrez EA; Chinen J; Byzova TV
J Thromb Haemost; 2012 Jul; 10(7):1397-408. PubMed ID: 22564402
[TBL] [Abstract][Full Text] [Related]
15. A LAD-III syndrome is associated with defective expression of the Rap-1 activator CalDAG-GEFI in lymphocytes, neutrophils, and platelets.
Pasvolsky R; Feigelson SW; Kilic SS; Simon AJ; Tal-Lapidot G; Grabovsky V; Crittenden JR; Amariglio N; Safran M; Graybiel AM; Rechavi G; Ben-Dor S; Etzioni A; Alon R
J Exp Med; 2007 Jul; 204(7):1571-82. PubMed ID: 17576779
[TBL] [Abstract][Full Text] [Related]
16. Defects in Glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: the role of integrin β1 and β3 in platelet adhesion to collagen.
van de Vijver E; De Cuyper IM; Gerrits AJ; Verhoeven AJ; Seeger K; Gutiérrez L; van den Berg TK; Kuijpers TW
Blood; 2012 Jan; 119(2):583-6. PubMed ID: 22065596
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of leukocyte recruitment and its deficiencies.
Schmidt S; Moser M; Sperandio M
Mol Immunol; 2013 Aug; 55(1):49-58. PubMed ID: 23253941
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium.
Karsan A; Cornejo CJ; Winn RK; Schwartz BR; Way W; Lannir N; Gershoni-Baruch R; Etzioni A; Ochs HD; Harlan JM
J Clin Invest; 1998 Jun; 101(11):2438-45. PubMed ID: 9616215
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation.
Svensson L; Howarth K; McDowall A; Patzak I; Evans R; Ussar S; Moser M; Metin A; Fried M; Tomlinson I; Hogg N
Nat Med; 2009 Mar; 15(3):306-12. PubMed ID: 19234463
[TBL] [Abstract][Full Text] [Related]
20. Leukocyte adhesion deficiencies.
Hanna S; Etzioni A
Ann N Y Acad Sci; 2012 Feb; 1250():50-5. PubMed ID: 22276660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
